|
|
||||||||
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
We examined the
hemodynamic and tubular transport mechanisms by which
platelet-activating factor (PAF) regulates salt and water excretion. In
anesthetized, renally denervated male Wistar rats, with raised systemic
blood pressure and renal arterial blood pressure maintained at normal
levels, intrarenal PAF infusion at 2.5 ng · min
1 · kg
1
resulted in a small fall in systemic blood pressure (no change in renal
arterial blood pressure) and an increase in renal blood flow and
urinary water, sodium, and potassium excretion rates. The PAF-induced
changes in cardiovascular and renal hemodynamic function were abolished
and renal excretory function greatly attenuated by treating rats with a
nitric oxide synthase inhibitor. To determine whether a tubular site of
action was involved in the natriuretic effect of PAF, cortical proximal
tubules were enzymatically dissociated from male Wistar rat kidneys,
and oxygen consumption rates (QO2) were used as
an integrated index of transcellular sodium transport. PAF at 1 nM
maximally inhibited QO2 in both untreated and
nystatin-stimulated (sodium entry into renal cell is not rate limiting)
proximal tubules by ~20%. Blockade of PAF receptors or
Na+-K+-ATPase pump activity with BN-52021 or
ouabain, respectively, abolished the effect of PAF on
nystatin-stimulated proximal tubule QO2.
Inhibition of nitric oxide synthase or guanylate cyclase systems did
not alter PAF-mediated inhibition of nystatin-stimulated proximal
tubule QO2, whereas phospholipase
A2 or cytochrome-P-450 monooxygenase inhibition
resulted in a 40-60% reduction. These findings suggest that
stimulation of PAF receptors on the proximal tubule decreases
transcellular sodium transport by activating phospholipase
A2 and the cytochrome-P-450 monooxygenase
pathways that lead to the inhibition of an ouabain-sensitive component of the basolateral Na+-K+-ATPase pump. Thus PAF
can activate both an arachidonate pathway-mediated suppression of
proximal tubule sodium transport and a nitric oxide pathway-mediated
dilatory action on renal hemodynamics that likely contributes to the
natriuresis and diuresis observed in vivo.
nitric oxide; vasopressin; blood pressure; renal blood flow; urinary water; electrolyte excretion; guanylate cyclase; phospholipase A2; cytochrome P-450 monooxygenase; sodium-potassium-adenosine 5'-triphosphatase; proximal tubule; oxygen consumption; rat
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |